Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review

BACKGROUND: Based on current evidence, recent guidelines of the National Institute of Health, USA indicated the use of remdesivir and dexamethasone for the treatment of COVID-19 patients with mild-moderate disease, not requiring high-flow oxygen. No therapeutic agent directed against the immunologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantini, Fabrizio, Goletti, Delia, Petrone, Linda, Najafi Fard, Saied, Niccoli, Laura, Foti, Rosario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568461/
https://www.ncbi.nlm.nih.gov/pubmed/33068263
http://dx.doi.org/10.1007/s40265-020-01421-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568461/
https://www.ncbi.nlm.nih.gov/pubmed/33068263
http://dx.doi.org/10.1007/s40265-020-01421-w

Ejemplares similares